Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors - AARD

Pomerantz LLP announced it has filed a class action against Aardvark Therapeutics, Inc. (NASDAQ: AARD) and certain officers and directors. The lawsuit was filed in the U.S. District Court for the Southern District of California under case number 26-cv-04643 and seeks claims under the Securities Act of 1933 and the Securities Exchange Act of 1934. The proposed class covers purchasers of Aardvark common stock tied to the company’s initial public offering around February 13, 2025, and those who bought Aardvark securities from February 13, 2025 through May 14, 2026. Investors have until October 13, 2026 to seek appointment as lead plaintiff.